While breast milk is undeniably the ultimate best food for infants, not all families are able to fully rely on it due to unavoidable factors such as low milk supply, underlying medical conditions or adoption.
In these instances, infant formula becomes a baby’s sole source of nutrition during early development.
Naturally, global food safety headlines would spark intense anxiety among parenting circles.
A major multi-country recall early this year (2026) – triggered by cereulide toxin contamination – impacted 99 nations globally, including our close neighbours in Singapore.
However, no affected products were reported to be on sale in Malaysia at the time.
Regardless, anxious parents still took to online forums to voice concerns about milk safety.
This article examines Malaysia’s response to food safety alerts, including the monitoring of imported infant formula products and actions taken when potentially affected batches are identified.
Heat-resistant toxin
Unlike traditional recalls caused by living bacteria, this crisis involved cereulide, a highly heat-stable chemical toxin produced by the bacterium Bacillus cereus.
Crucially, the contamination did not originate from raw cow’s milk, but from a single upstream supplier of arachidonic acid (ARA) oil – a premium fatty acid added to mimic the compositional structure of breast milk.
Because the supplier heat-treated the oil, the live bacteria were destroyed, allowing the ingredient batch to pass standard microbiological screening undetected.
However, the pre-secreted, heat-resistant chemical toxin remained fully active in the finished powder.
Why didn’t this hit Malaysia’s supermarket shelves?
Several factors may have limited the impact in our country, including regional supply and logistic arrangements and the monitoring of imported products by the Health Ministry’s (MOH’s) Food Safety and Quality Division.
The vast majority of mainstream premium infant formulas sold on Malaysian shelves are blended and canned in highly specialised, dedicated regional facilities that utilised entirely separate, non-impacted batches of nutritional additives.
In addition, the MOH maintains a strict multi-tiered import clearance protocol under the Malaysian Food Regulations 1985.
The moment the global Infosan (International Food Safety Authorities Network) alert was raised, the MOH immediately cross-referenced batch numbers and shipping manifests.
Suspect shipments from European factories utilising the compromised ARA oil pipeline were blocked at our ports of entry before they could enter the country.
How Singapore handled it
Across the Causeway, the Singapore Food Agency (SFA) also dealt promptly with the fallout.
On Jan 8 (2026), they issued immediate stop-sale orders for the initial suspected batches.
The SFA ramped up their market surveillance and systematically tested formula products across major retail outlets.
When they discovered that the compromised raw ingredient was used in other products, they issued precautionary recalls for several more batches just to be safe.
They also locked down their exports, directing a local manufacturer to halt shipping out affected tins.
Meanwhile, Singapore’s Communicable Diseases Agency (CDA) teamed up with doctors on the ground to actively track potential poisoning cases.
Thanks to the quick recalls and clear public advisories – warning parents to discard suspected milk and look out for symptoms like persistent vomiting – only three mild cases were detected, and thankfully, all those babies fully recovered.
Infant formula is one of the very few consumer products where a single error at any stage of the chain – from the farm to the processing plant to the retail shelf – can lead to catastrophic outcomes.
Thus, every government, including ours, treats infant formula with extreme caution.
In fact, it is treated almost like a pharmaceutical product, rather than regular food.
Dr Kek Chee Yen is a general practitioner (GP) and president of the Private Medical Practitioners’ Association of Selangor and Kuala Lumpur (PMPASKL). For more information, email starhealth@thestar.com.my. The information provided is for educational and communication purposes only, and should not be considered as medical advice. The Star does not give any warranty on accuracy, completeness, functionality, usefulness or other assurances as to the content appearing in this article. The Star disclaims all responsibility for any losses, damage to property or personal injury suffered directly or indirectly from reliance on such information.
